Literature DB >> 8448245

Monoclonal gammopathy of unknown significance in a bone marrow donor.

S O Peters1, M Stockschläder, W Zeller, K Mross, M Dürken, W Krüger, A R Zander.   

Abstract

We report on a patient suffering from multiple myeloma, for whom allogeneic bone marrow transplantation was planned. Donor workup revealed monoclonal gammopathy of unknown significance. We discuss this finding and stress the importance of performing complete donor examinations.

Entities:  

Mesh：

Year:  1993        PMID： 8448245     DOI： 10.1007/bf01695891

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  9 in total

1.  The survival time of patients with plasmocytic myeloma.

Authors:  E E OSGOOD
Journal:  Cancer Chemother Rep       Date:  1960-11

2.  Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.

Authors:  W M Gregory; M A Richards; J S Malpas
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544

Review 3.  Autologous bone marrow transplantation for multiple myeloma.

Authors:  S Jagannath; B Barlogie
Journal:  Hematol Oncol Clin North Am       Date:  1992-04       Impact factor: 3.722

4.  Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia.

Authors:  D W Niederwieser; F R Appelbaum; G Gastl; E Gersdorf; B Meister; D Geissler; J A Tratkiewicz; J Thaler; C Huber
Journal:  N Engl J Med       Date:  1990-06-21       Impact factor: 91.245

5.  Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens.

Authors:  R Alexanian; A Haut; A U Khan; M Lane; E M McKelvey; P J Migliore; W J Stuckey; H E Wilson
Journal:  JAMA       Date:  1969-06-02       Impact factor: 56.272

6.  Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

Authors:  F Mandelli; G Avvisati; S Amadori; M Boccadoro; A Gernone; V M Lauta; F Marmont; M T Petrucci; M Tribalto; M L Vegna
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

7.  Marrow harvesting from normal donors.

Authors:  C D Buckner; R A Clift; J E Sanders; P Stewart; W I Bensinger; K C Doney; K M Sullivan; R P Witherspoon; H J Deeg; F R Appelbaum
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

8.  The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia.

Authors:  D E Bergsagel; A J Bailey; G R Langley; R N MacDonald; D F White; A B Miller
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

9.  Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation.

Authors:  G Gahrton; S Tura; P Ljungman; C Belanger; L Brandt; M Cavo; T Facon; A Granena; M Gore; A Gratwohl
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.